www.axios.com /2026/08/14/biological-threats-ai-lab-research

A convergence of biological risks

Caitlin Owens 5-6 minutes 8/14/2026

What's the common thread connecting AI advances, biological breakthroughs, a preponderance of high-risk-high-reward research, escalating geopolitical tensions and a hollowed-out U.S. public health sector?

Why it matters: The same advances that make this a pivotal moment for medical innovation are intensifying the risk of catastrophic lab mishaps, though how significant a risk is hotly debated by experts.

The big picture: There are plenty of grim scenarios. A bad actor could use an AI-enabled bioweapon to cause mass casualties around the world.

But the ways in which the world has become more dangerous since the pandemic may be underappreciated, Jha told Axios.

Driving the news: Last week's news that Stanford researchers used AI to create new synthetic viruses from scratch ratcheted up concerns that nefarious actors around the world could be attempting similar feats with more complex organisms.

Reality check: This AI-enabled biology still involves a huge amount of manual lab work — a barrier to any weaponization plans.

Yes, but: AI is constantly evolving, and last week's groundbreaking news was first revealed in a preprint manuscript nearly a year ago, so who knows what advancements in synthetic biology have been made since.

Where it stands: "China, North Korea, and Russia probably maintain the knowledge and capability to produce and employ traditional biological pathogens and toxins, and historically have pursued ... pathogens that cause highly infectious or contagious diseases," this year's annual threat assessment from the U.S. intelligence community states.

The other side: AI can also be used to bolster biodefense, and Google DeepMind last month announced its own bioresilience program that aims to prevent, detect and respond to biological threats.